Segall Bryant & Hamill LLC Sells 4,029 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Segall Bryant & Hamill LLC trimmed its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 1.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 299,438 shares of the company’s stock after selling 4,029 shares during the period. Segall Bryant & Hamill LLC owned approximately 0.24% of Surgery Partners worth $6,339,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Surgery Partners by 2.3% during the fourth quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company’s stock valued at $161,282,000 after purchasing an additional 172,271 shares during the period. LPL Financial LLC raised its stake in shares of Surgery Partners by 22.4% in the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company’s stock valued at $355,000 after buying an additional 3,062 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Surgery Partners during the 4th quarter valued at about $273,000. Sei Investments Co. increased its stake in Surgery Partners by 13.9% in the fourth quarter. Sei Investments Co. now owns 43,666 shares of the company’s stock valued at $924,000 after acquiring an additional 5,333 shares during the period. Finally, American Century Companies Inc. raised its position in Surgery Partners by 223.9% in the fourth quarter. American Century Companies Inc. now owns 1,399,756 shares of the company’s stock worth $29,633,000 after purchasing an additional 967,534 shares in the last quarter.

Surgery Partners Trading Down 0.7 %

Shares of NASDAQ SGRY opened at $24.02 on Thursday. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $33.97. The company has a 50-day moving average of $24.16 and a two-hundred day moving average of $25.64. The company has a market cap of $3.07 billion, a PE ratio of -50.04, a P/E/G ratio of 19.21 and a beta of 2.73. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.01. The firm had revenue of $864.40 million during the quarter, compared to analysts’ expectations of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. As a group, equities analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on SGRY shares. JPMorgan Chase & Co. decreased their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a report on Tuesday, December 3rd. Macquarie lowered their price target on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 11th. Bank of America began coverage on Surgery Partners in a report on Monday, December 16th. They set a “buy” rating and a $30.00 price objective for the company. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $35.00 target price on shares of Surgery Partners in a research report on Tuesday. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $36.63.

Insider Activity

In other Surgery Partners news, CFO David T. Doherty sold 13,641 shares of the company’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the transaction, the chief financial officer now directly owns 108,862 shares in the company, valued at approximately $2,787,955.82. This represents a 11.14 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now owns 107,037 shares of the company’s stock, valued at approximately $2,744,428.68. This represents a 34.47 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 106,622 shares of company stock valued at $2,717,860 over the last 90 days. 2.30% of the stock is owned by company insiders.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.